Conventional Radiotherapy and Stereotactic Radiosurgery in the Management of Metastatic Spine Disease

Conventional Radiotherapy and Stereotactic Radiosurgery in the Management of Metastatic Spine Disease

Spinal metastases are a common manifestation of malignant tumors that can cause severe pain, spinal cord compression, pathological fractures, and hypercalcemia, and these clinical manifestations will ultimately reduce the health-related quality of life and even shorten life expectancy in patient wit...

Full description

Bibliographic Details
Main Authors:	Hao-ran Zhang MD, Ji-kai Li MD, Xiong-gang Yang MD, Rui-qi Qiao MD, Yong-Cheng Hu MD, PhD
Format:	Article
Language:	English
Published:	SAGE Publishing 2020-08-01
Series:	Technology in Cancer Research & Treatment
Online Access:	https://doi.org/10.1177/1533033820945798

Similar Items

Single fraction stereotactic radiosurgery for multiple brain metastases
by: Dror Limon, MD, et al.
Published: (2017-10-01)

Efficacy and Safety of Primary Stereotactic Radiosurgery in Patients With Intraventricular Meningiomas
by: Sebastian M. Christ, MD, PhD, et al.
Published: (2023-01-01)

A Cohort Study of Stereotactic Radiosurgery Results for Patients With 5 to 15 Versus 2 to 4 Brain Metastatic Tumors
by: Masaaki Yamamoto, MD, PhD, et al.
Published: (2020-05-01)

Stereotactic Radiosurgery in the Management of Brain Metastases: A Case-Based Radiosurgery Society Practice Guideline
by: Colton Ladbury, MD, et al.
Published: (2024-03-01)

The Effect of Slice Thickness on Contours of Brain Metastases for Stereotactic Radiosurgery
by: Sara L. Thrower, PhD, et al.
Published: (2021-07-01)

Early Detection of Leptomeningeal Metastases Among Patients Undergoing Spinal Stereotactic Radiosurgery
by: Morgan E. Freret, MD, PhD, et al.
Published: (2023-03-01)

Stereotactic Radiosurgery for Brain Metastases in Patients With Small Cell Lung Cancer
by: Victoria H. Wang, BS, et al.
Published: (2023-09-01)

Outcomes in Patients with Intact and Resected Brain Metastasis Treated with 5-Fraction Stereotactic Radiosurgery
by: David J. Carpenter, MD, et al.
Published: (2023-03-01)

Stereotactic Radiosurgery and Stereotactic Fractionated Radiotherapy in the Management of Brain Metastases
by: Sofian Benkhaled, et al.
Published: (2024-03-01)

A feasibility study of stereotactic radiosurgery/stereotactic body radiotherapy/stereotactic ablative radiotherapy practice using tomoedge in helical tomotherapy for lung, liver, and spine targets
by: N V. N. Madhusudhana Sresty, et al.
Published: (2021-01-01)

Stereotactic Radiosurgery/Radiotherapy: A Historical Review
by: Mansoureh Nabavi, et al.
Published: (2014-04-01)

Single-Isocenter Multitarget Stereotactic Radiosurgery Is Safe and Effective in the Treatment of Multiple Brain Metastases
by: Joshua D. Palmer, MD, et al.
Published: (2020-01-01)

Radiation Therapy Practice Patterns for Brain Metastases in the United States in the Stereotactic Radiosurgery Era
by: Andrew B. Barbour, PhD, et al.
Published: (2020-01-01)

Recent Advances and Challenges in Stereotactic Body Radiotherapy
by: Atsuto Katano MD, PhD, et al.
Published: (2024-02-01)

Management of Adverse Radiation Effect Associated with Stereotactic Radiosurgery of Brain Metastasis in Multiple Sclerosis
by: Elisa K. Liu, BS, et al.
Published: (2023-03-01)

A Pilot Study of Pembrolizumab Combined With Stereotactic Ablative Radiotherapy for Patients With Advanced or Metastatic Sarcoma
by: Jeremy P. Harris MD, MPhil, et al.
Published: (2024-02-01)

Feasibility and safety of cavity-directed stereotactic radiosurgery for brain metastases at a high-volume medical center
by: Paul Rava, MD PhD, et al.
Published: (2016-07-01)

A framework for exactrac dynamic commissioning for stereotactic radiosurgery and stereotactic ablative radiotherapy
by: Ben Perrett, et al.
Published: (2022-01-01)

Distant intracranial failure in melanoma brain metastases treated with stereotactic radiosurgery in the era of immunotherapy and targeted agents
by: Sahaja Acharya, MD, et al.
Published: (2017-10-01)

Rodent Model of Brain Radionecrosis Using Clinical LINAC-Based Stereotactic Radiosurgery
by: Sean P. Devan, MS, et al.
Published: (2022-11-01)

Nivolumab and Stereotactic Radiosurgery for Patients With Breast Cancer Brain Metastases: A Nonrandomized, Open-Label Phase 1b Study
by: Kamran A. Ahmed, MD, et al.
Published: (2021-11-01)

The Judicious Use of Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy in the Management of Large Brain Metastases
by: Tyler Gutschenritter, et al.
Published: (2020-12-01)

Cognitive effects of stereotactic radiosurgery in adult patients with brain metastases: A systematic review
by: Wietske C.M. Schimmel, MSc, et al.
Published: (2018-10-01)

Radiosurgery and fractionated stereotactic body radiotherapy for patients with lung oligometastases
by: Goda G. Kalinauskaite, et al.
Published: (2020-05-01)

Role of Radiosurgery/Stereotactic Radiotherapy in Oligometastatic Disease: Brain Oligometastases
by: Rosario Mazzola, et al.
Published: (2019-04-01)

Preoperative Dural Contact and Recurrence Risk After Surgical Cavity Stereotactic Radiosurgery for Brain Metastases: New Evidence in Support of Consensus Guidelines
by: Matthew Susko, MD, et al.
Published: (2019-07-01)

Single Fraction Frameless Stereotactic Radiosurgery on the Gamma Knife Icon for Patients With Brain Metastases: Time to Abandon the Frame?
by: Rodney E. Wegner, MD, et al.
Published: (2021-09-01)

Factors Associated With New-Onset Seizures Following Stereotactic Radiosurgery for Newly Diagnosed Brain Metastases
by: Emily C. Lerner, BA, et al.
Published: (2022-11-01)

CyberKnife Stereotactic Radiosurgery for Recurrent, Metastatic, and Residual Hemangiopericytomas
by: Soltys Scott G, et al.
Published: (2011-06-01)

Hippocampal Dosimetry and the Necessity of Hippocampal-Sparing in Gamma Knife Stereotactic Radiosurgery for Extensive Brain Metastases
by: Matthew D. Riina, BS, et al.
Published: (2020-03-01)

The experience of stereotactic radiosurgery and radiotherapy use in combined treatment of pituitary adenomas
by: Andrey Gryazov, et al.
Published: (2015-05-01)

Perfusion and Volume Response of Canine Brain Tumors to Stereotactic Radiosurgery and Radiotherapy
by: A.L. Zwingenberger, et al.
Published: (2016-05-01)

How Does the Number of Brain Metastases Correlate With Normal Brain Exposure in Single-Isocenter Multitarget Multifraction Stereotactic Radiosurgery
by: Dandan Zheng, PhD, et al.
Published: (2024-06-01)

Single and Multifraction Spine Stereotactic Body Radiation Therapy and the Risk of Radiation Induced Myelopathy
by: J. John Lucido, PhD, et al.
Published: (2022-11-01)

Tufts Medical Center Experience With Long-Term Follow-Up of Vestibular Schwannoma Treated With Gamma Knife Stereotactic Radiosurgery: Novel Finding of Delayed Pseudoprogression
by: Justin Wage, MD, et al.
Published: (2021-07-01)

Plan Assessment Metrics for Dose Painting in Stereotactic Radiosurgery
by: Benjamin Z. Tham, MSc, et al.
Published: (2023-11-01)

Internal dose escalation is associated with increased local control for non-small cell lung cancer (NSCLC) brain metastases treated with stereotactic radiosurgery (SRS)
by: Christopher Abraham, MD, et al.
Published: (2018-04-01)

Feasibility of linac-based fractionated stereotactic radiotherapy and stereotactic radiosurgery for patients with up to ten brain metastases
by: Masanori Hirata, et al.
Published: (2022-12-01)

Outcomes in Patients With 4 to 10 Brain Metastases Treated With Dose-Adapted Single-Isocenter Multitarget Stereotactic Radiosurgery: A Prospective Study
by: Grace J. Kim, MD, PhD, et al.
Published: (2021-11-01)

Radiation-Induced Peripheral Neuropathy After Thoracic Stereotactic Ablative Radiotherapy: Case Report
by: Ha H. Pham, MD, PhD, et al.
Published: (2022-08-01)